Yang Zhiqiang, Sun Qiaoling, Chen Shang, Ding Shuangyang, Zhang Rong, Zhu Kui
National Center for Veterinary Drug Safety Evaluation, College of Veterinary Medicine, China Agricultural University, Beijing, China.
Department of Clinical Laboratory, The Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, China.
Microb Drug Resist. 2021 Aug;27(8):1117-1125. doi: 10.1089/mdr.2020.0225. Epub 2020 Dec 23.
The emerging epidemic of carbapenem-resistant (CRKP) is a global public health crisis. However, the phylogenetic affiliation and pathotypic status of CRKP strains in the host colonization period under consistent antibiotic treatments are not well characterized. In this study, a 5-year tracking study was performed, in which a patient admitted to an intensive care unit was recruited and then screened for the carriage of CRKP based on microbiological culture. Nine isolates from the sputum or stool samples were acquired and subjected to real-time whole-genome sequencing, antimicrobial susceptibility testing, larval infection, and epithelial cell invasion assay. All nine isolates showed phenotypic resistance to carbapenems, quinolones, and aminoglycosides. Altogether, and 10 other antibiotic resistance genes were identified and all nine CRKP isolates exhibited low virulence with more than 38 virulence factors. All but one variant belonged to ST11 with a novel sequence type, differing at the locus. The isolates shared the same plasmid replicon type, prophages, and capsular serotype (K47) with few single-nucleotide polymorphism variations, consistent with epidemiological clones. Furthermore, these CRKP isolates displayed the ability of moderate invasion of lung epithelial cells. Meanwhile, a deficiency of chromosomal type IV secretion system-related gene cluster was detected after 2 years of carriage. Our findings demonstrated that low-virulence CRKP clones could colonize in the gut and respiratory tract under multiple antibiotic stresses, suggesting the strong colonization adaptability of CRKP to the host. Ethical approval was given by The Second Affiliated Hospital of Zhejiang University, School of Medicine, (2018-039).
耐碳青霉烯类肺炎克雷伯菌(CRKP)的出现是一场全球公共卫生危机。然而,在持续抗生素治疗下,CRKP菌株在宿主定植期的系统发育归属和致病型状态尚未得到充分表征。在本研究中,进行了一项为期5年的跟踪研究,招募了一名入住重症监护病房的患者,然后基于微生物培养对其进行CRKP携带情况筛查。从痰液或粪便样本中获取了9株分离株,并对其进行了实时全基因组测序、药敏试验、幼虫感染和上皮细胞侵袭试验。所有9株分离株均表现出对碳青霉烯类、喹诺酮类和氨基糖苷类的表型耐药性。总共鉴定出10个其他抗生素耐药基因,所有9株CRKP分离株均表现出低毒力,具有超过38种毒力因子。除一个变体外,所有变体均属于ST11,具有一种新的序列类型,在 位点存在差异。这些分离株具有相同的质粒复制子类型、原噬菌体和荚膜血清型(K47),单核苷酸多态性变异很少,与流行病学克隆一致。此外,这些CRKP分离株表现出对肺上皮细胞的中度侵袭能力。同时,在携带2年后检测到染色体IV型分泌系统相关基因簇存在缺陷。我们的研究结果表明,低毒力的CRKP克隆可以在多种抗生素压力下在肠道和呼吸道定植,提示CRKP对宿主具有很强的定植适应性。本研究已获得浙江大学医学院附属第二医院伦理批准(2018 - 039)。